Subscribe to RSS
DOI: 10.1055/a-2802-3804
Joint Effect of Muscle Strength and Obesity on the Risk of Venous Thromboembolism
Authors
Funding Information O.G.R.L. is supported by an independent grant from the public Northern Norwegian Health authorities.

Abstract
Background
Weak hand grip strength (HGS) and obesity separately increase the risk of venous thromboembolism (VTE). Whether the combination of these risk factors yields excess VTE risk is unclear. We aimed to investigate the joint effect of HGS and obesity on the risk of VTE in a population-based cohort.
Methods
A total of 13,616 participants from the Tromsø study (enrolled: 1994–2016) were included, and incident VTEs were recorded throughout 2020. HGS was categorized into weak (≤25th percentile) and normal (>25th percentile). Obesity was defined as a body mass index ≥ 30 kg/m2. Cox regression was applied to estimate hazard ratios (HRs) with 95% confidence intervals (CI) according to combined categories of HGS and obesity adjusted for age, sex, height, cardiovascular disease, cancer, and physical activity. Relative excess risk due to interaction (RERI) and attributable proportion (AP) were calculated with 95% CI.
Results
The combination of weak HGS and obesity yielded an additive 1.8-fold increased risk of overall VTE (95% CI: 1.25–2.55) compared with nonobese individuals with normal HGS. The corresponding HR was 1.23 (95% CI: 0.97–1.56) in nonobese with weak HGS, and 1.47 (95% CI: 1.14–1.90) in obese with normal HGS. In subgroup analyses of unprovoked VTE, risk estimates were supra-additive in those obese with weak HGS (HR: 2.68, (95% CI: 1.64–4.37), RERI 1.63 (95% CI: 0.36–2.91), AP 0.61 (95% CI: 0.34–0.88)), supporting biological interaction between the exposures.
Conclusion
The joint effect of weak HGS and obesity was additive for overall VTE, and supra-additive for unprovoked VTE, where 61% of the unprovoked VTEs in the combined category could be attributed to the interaction between HGS and obesity.
Keywords
venous thrombosis - obesity - muscle strength - deep vein thrombosis - unprovoked venous thromboembolismContributors' Statement
J.B.H. and S.K.B. contributed to conception, design, and critical revision of manuscript. O.G.R.L. and S.K.B. contributed to statistical analysis. O.G.R.L., J.B.H., and S.K.B. contributed to interpretation of results. O.G.R.L. contributed to draft of manuscript. Approval of submitted version: all authors.
Publication History
Received: 10 November 2025
Accepted: 31 January 2026
Article published online:
13 February 2026
© 2026. Thieme. All rights reserved.
Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
-
References
- 1 Arshad N, Isaksen T, Hansen JB, Brækkan SK. Time trends in incidence rates of venous thromboembolism in a large cohort recruited from the general population. Eur J Epidemiol 2017; 32 (04) 299-305
- 2 Arnesen CAL, Veres K, Horváth-Puhó E, Hansen JB, Sørensen HT, Brækkan SK. Estimated lifetime risk of venous thromboembolism in men and women in a Danish nationwide cohort: impact of competing risk of death. Eur J Epidemiol 2022; 37 (02) 195-203
- 3 Dodds RM, Syddall HE, Cooper R. et al. Grip strength across the life course: normative data from twelve British studies. PLoS One 2014; 9 (12) e113637
- 4 McLeod M, Breen L, Hamilton DL, Philp A. Live strong and prosper: the importance of skeletal muscle strength for healthy ageing. Biogerontology 2016; 17 (03) 497-510
- 5 Cruz-Jentoft AJ, Bahat G, Bauer J. et al; Writing Group for the European Working Group on Sarcopenia in Older People 2 (EWGSOP2), and the Extended Group for EWGSOP2. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing 2019; 48 (01) 16-31
- 6 Strandkvist V, Larsson A, Pauelsen M. et al. Hand grip strength is strongly associated with lower limb strength but only weakly with postural control in community-dwelling older adults. Arch Gerontol Geriatr 2021; 94: 104345
- 7 Bohannon RW, Magasi SR, Bubela DJ, Wang Y-C, Gershon RC. Grip and knee extension muscle strength reflect a common construct among adults. Muscle Nerve 2012; 46 (04) 555-558
- 8 Bohannon RW. Muscle strength: clinical and prognostic value of hand-grip dynamometry. Curr Opin Clin Nutr Metab Care 2015; 18 (05) 465-470
- 9 Aadahl M, Beyer N, Linneberg A, Thuesen BH, Jørgensen T. Grip strength and lower limb extension power in 19-72-year-old Danish men and women: the Health 2006 study. BMJ Open 2011; 1 (02) e000192
- 10 Wind AE, Takken T, Helders PJM, Engelbert RHH. Is grip strength a predictor for total muscle strength in healthy children, adolescents, and young adults?. Eur J Pediatr 2010; 169 (03) 281-287
- 11 Leknessund OGR, Morelli VM, Strand BH, Hansen JB, Brækkan SK. Hand grip strength and risk of incident venous thromboembolism: the Tromsø study. Res Pract Thromb Haemost 2022; 6 (07) e12833
- 12 Engbers MJ, Blom JW, Cushman M, Rosendaal FR, van Hylckama Vlieg A. Functional impairment and risk of venous thrombosis in older adults. J Am Geriatr Soc 2017; 65 (09) 2003-2008
- 13 Folsom AR, Boland LL, Cushman M, Heckbert SR, Rosamond WD, Walston JD. Frailty and risk of venous thromboembolism in older adults. J Gerontol A Biol Sci Med Sci 2007; 62 (01) 79-82
- 14 Kunutsor SK, Mäkikallio TH, Voutilainen A, Laukkanen JA. Handgrip strength is not associated with risk of venous thromboembolism: a prospective cohort study. Scand Cardiovasc J 2020; 54 (04) 253-257
- 15 Gao Y, Chen H, Ke D, Li C, Jiang Z, Pu B. Effect of muscle strength on deep vein thrombosis: a Mendelian randomization study. Medicine (Baltimore) 2024; 103 (45) e40138
- 16 Frischmuth T, Tøndel BG, Brækkan SK, Hansen JB, Morelli VM. The risk of incident venous thromboembolism attributed to overweight and obesity: the Tromsø study. Thromb Haemost 2024; 124 (03) 239-249
- 17 Braekkan SK, Siegerink B, Lijfering WM, Hansen JB, Cannegieter SC, Rosendaal FR. Role of obesity in the etiology of deep vein thrombosis and pulmonary embolism: current epidemiological insights. Semin Thromb Hemost 2013; 39 (05) 533-540
- 18 Rahmani J, Haghighian Roudsari A, Bawadi H. et al. Relationship between body mass index, risk of venous thromboembolism and pulmonary embolism: a systematic review and dose-response meta-analysis of cohort studies among four million participants. Thromb Res 2020; 192: 64-72
- 19 Heit JA, Ashrani A, Crusan DJ, McBane RD, Petterson TM, Bailey KR. Reasons for the persistent incidence of venous thromboembolism. Thromb Haemost 2017; 117 (02) 390-400
- 20 Klovaite J, Benn M, Nordestgaard BG. Obesity as a causal risk factor for deep venous thrombosis: a Mendelian randomization study. J Intern Med 2015; 277 (05) 573-584
- 21 Klarin D, Emdin CA, Natarajan P, Conrad MF, Kathiresan S. INVENT Consortium. Genetic analysis of venous thromboembolism in UK Biobank identifies the ZFPM2 locus and implicates obesity as a causal risk factor. Circ Cardiovasc Genet 2017; 10 (02) e001643
- 22 Lindström S, Germain M, Crous-Bou M. et al; INVENT Consortium. Assessing the causal relationship between obesity and venous thromboembolism through a Mendelian randomization study. Hum Genet 2017; 136 (07) 897-902
- 23 Borch KH, Nyegaard C, Hansen JB. et al. Joint effects of obesity and body height on the risk of venous thromboembolism: the Tromsø study. Arterioscler Thromb Vasc Biol 2011; 31 (06) 1439-1444
- 24 Frischmuth T, Hindberg K, Gabrielsen ME. et al. Joint effect of multiple prothrombotic genotypes and obesity on the risk of incident venous thromboembolism. Thromb Haemost 2022; 122 (02) 267-276
- 25 Pomp ER, le Cessie S, Rosendaal FR, Doggen CJ. Risk of venous thrombosis: obesity and its joint effect with oral contraceptive use and prothrombotic mutations. Br J Haematol 2007; 139 (02) 289-296
- 26 Sejrup JK, Tøndel BG, Morelli VM. et al. Joint effect of myocardial infarction and obesity on the risk of venous thromboembolism: the Tromsø study. J Thromb Haemost 2022; 20 (10) 2342-2349
- 27 Larsson SC, Bäck M, Rees JMB, Mason AM, Burgess S. Body mass index and body composition in relation to 14 cardiovascular conditions in UK Biobank: a Mendelian randomization study. Eur Heart J 2020; 41 (02) 221-226
- 28 Willenberg T, Schumacher A, Amann-Vesti B. et al. Impact of obesity on venous hemodynamics of the lower limbs. J Vasc Surg 2010; 52 (03) 664-668
- 29 Arfvidsson B, Eklof B, Balfour J. Iliofemoral venous pressure correlates with intraabdominal pressure in morbidly obese patients. Vasc Endovascular Surg 2005; 39 (06) 505-509
- 30 Houghton DE, Ashrani A, Liedl D. et al. Reduced calf muscle pump function is a risk factor for venous thromboembolism: a population-based cohort study. Blood 2021; 137 (23) 3284-3290
- 31 Kügler C, Strunk M, Rudofsky G. Venous pressure dynamics of the healthy human leg. Role of muscle activity, joint mobility and anthropometric factors. J Vasc Res 2001; 38 (01) 20-29
- 32 Di Nisio M, Di Iorio A, Porreca E. et al. Obesity, poor muscle strength, and venous thromboembolism in older persons: the InCHIANTI study. J Gerontol A Biol Sci Med Sci 2011; 66 (03) 320-325
- 33 World Health Organization, 2025. Fact sheet: Obesity and overweight. Accessed November 7, 2025; available at: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight
- 34 Evensen LH, Isaksen T, Hindberg K, Braekkan SK, Hansen JB. Repeated assessments of physical activity and risk of incident venous thromboembolism. J Thromb Haemost 2018; 16 (11) 2208-2217
- 35 Kurtze N, Rangul V, Hustvedt BE, Flanders WD. Reliability and validity of self-reported physical activity in the Nord-Trøndelag Health Study (HUNT 2). Eur J Epidemiol 2007; 22 (06) 379-387
- 36 Kurtze N, Rangul V, Hustvedt BE, Flanders WD. Reliability and validity of self-reported physical activity in the Nord-Trøndelag Health Study: HUNT 1. Scand J Public Health 2008; 36 (01) 52-61
- 37 Leknessund OGR, Morelli VM, Hansen JB, Brækkan SK. Hand grip strength in venous thromboembolism: risk of recurrence and mortality. Res Pract Thromb Haemost 2023; 7 (05) 102138
- 38 Jacobsen BK, Eggen AE, Mathiesen EB, Wilsgaard T, Njølstad I. Cohort profile: the Tromso study. Int J Epidemiol 2012; 41 (04) 961-967
- 39 Hopstock LA, Grimsgaard S, Johansen H, Kanstad K, Wilsgaard T, Eggen AE. The seventh survey of the Tromsø Study (Tromsø7) 2015-2016: study design, data collection, attendance, and prevalence of risk factors and disease in a multipurpose population-based health survey. Scand J Public Health 2022; 50 (07) 919-929
- 40 Rothman KJ, Huybrechts KF, Murray EJ. Epidemiology: an introduction. New York, NY: : New York, NY: Oxford University Press; 2024
- 41 Heit JA. Epidemiology of venous thromboembolism. Nat Rev Cardiol 2015; 12 (08) 464-474
- 42 Arshad N, Bjøri E, Hindberg K, Isaksen T, Hansen JB, Braekkan SK. Recurrence and mortality after first venous thromboembolism in a large population-based cohort. J Thromb Haemost 2017; 15 (02) 295-303
- 43 Khan F, Rahman A, Carrier M. et al; MARVELOUS Collaborators. Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event: systematic review and meta-analysis. BMJ 2019; 366: l4363
- 44 Samson MM, Meeuwsen IB, Crowe A, Dessens JA, Duursma SA, Verhaar HJ. Relationships between physical performance measures, age, height and body weight in healthy adults. Age Ageing 2000; 29 (03) 235-242
- 45 Norman K, Stobäus N, Smoliner C. et al. Determinants of hand grip strength, knee extension strength and functional status in cancer patients. Clin Nutr 2010; 29 (05) 586-591
- 46 Mammen EF. Pathogenesis of venous thrombosis. Chest 1992; 102 (06) 640S-644S
- 47 Almen T, Nylander G. Serial phlebography of the normal lower leg during muscular contraction and relaxation. Acta Radiol 1962; 57: 264-272
- 48 Engelberger RP, Indermühle A, Baumann F. et al. Diurnal changes of lower leg volume in obese and non-obese subjects. Int J Obes 2014; 38 (06) 801-805
- 49 Ouchi N, Parker JL, Lugus JJ, Walsh K. Adipokines in inflammation and metabolic disease. Nat Rev Immunol 2011; 11 (02) 85-97
- 50 Skurk T, Hauner H. Obesity and impaired fibrinolysis: role of adipose production of plasminogen activator inhibitor-1. Int J Obes Relat Metab Disord 2004; 28 (11) 1357-1364